Modern Medicine and the 20th Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs
This paper studies the contribution of sulfa drugs, a groundbreaking medical innovation in the 1930s, to declines in U.S. mortality. For several often-fatal infectious diseases, sulfa drugs represented the first effective treatment. Using time-series and difference-in-differences methods (with diseases unaffected by sulfa drugs as a comparison group), we find that sulfa drugs led to a 25 to 40 percent decline in maternal mortality, 17 to 36 percent decline in pneumonia mortality, and 52 to 67 percent decline in scarlet-fever mortality between 1937 and 1943. Altogether, they reduced mortality by 2 to 4 percent and increased life expectancy by 0.4 to 0.8 years. We also find that sulfa drugs benefited whites more than blacks.
|Date of creation:||Jun 2009|
|Date of revision:|
|Publication status:||published as “Modern Medicine and the 20th-Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs,” (with A. Lleras-Muney and K. Smith), American Economic Journal: Applied Economics, 2(2), April 2010, pp. 118-146|
|Note:||DAE HC HE|
|Contact details of provider:|| Postal: |
Web page: http://www.nber.org
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:nbr:nberwo:15089. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ()
If references are entirely missing, you can add them using this form.